Page last updated: 2024-10-30

lansoprazole and Calcinosis

lansoprazole has been researched along with Calcinosis in 1 studies

Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.

Calcinosis: Pathologic deposition of calcium salts in tissues.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Arita, Y1
Nakayama, M1
Matsukuma, Y1
Yoshitomi, R1
Seki, M1
Fukui, A1
Tsuda, S1
Sonoda, Y1
Imazu, R1
Arakawa, K1
Tominaga, M1
Nakano, T1
Tsuruya, K1
Kitazono, T1

Other Studies

1 other study available for lansoprazole and Calcinosis

ArticleYear
Association of aortic valve calcification with carotid artery lesions and peripheral artery disease in patients with chronic kidney disease: a cross-sectional study.
    BMC nephrology, 2020, 05-29, Volume: 21, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Ankle Brachial Index; Aortic Valve; Aortic Valve Stenosis; Calcinosi

2020